- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Current State of the Pharma Sales and Marketing Sales Force
Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion
Executive Roundtable Participants:
- Ian Baer, Founder and Chief Soothsayer, Sooth
- Andrew Bast, Chief Strategy Officer, Greater Than One
- Jay Shah, Senior Solutions Engineer, MMIT
- Simon Arkell, CEO and Co-Founder, Ryght
- Glen Saunders, VP of Product Management and Strategy, Skipta
- John Kenny, SVP and Head of Strategic Planning, EVERSANA
Moderated by Mike Hollan
Video edited by Miranda Schmalfuhs
Pricing Climate Impacting Commercial Considerations
May 3rd 2024In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, talks about the influence of Medicare Part D drug price negotiations on manufacturer go-to-market strategies and decision-making, and the industry’s response to the wider dialogue on pricing transparency.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.
